BRAIN Biotech AG

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra Other stock markets 11:35:43 2026-02-10 am EST			5-day change	1st Jan Change
2.280 ^EUR	+4.59%		+3.64%	-9.52%

Jan. 20	BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026
Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI

BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026

Published on 01/14/2026 at 01:30 am EST

S&P Capital IQ

BRAIN BIOTECH AG

+4.59%

BRAIN Biotech AG provided revenue guidance for the year 2025/2026. For the financial year, BRAIN Biotech expects a small increase in group revenues vs. the previous financial year.

Latest news about BRAIN Biotech AG

Jan. 20	BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026
Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI
Jan. 13	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2025	CI
25-09-03	BRAIN Biotech AG Announces Executive Changes	CI
25-08-28	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
25-08-28	BRAIN Biotech AG Updates Sales Guidance for the Year 2025	CI
25-08-25	Corbion, BRAIN Biotech to Jointly Develop Biobased Antimicrobial Compounds	MT
25-08-25	Corbion and Brain Biotech Ag Team to Shape the Future of Innovation in Nature-Based Ingredient Technologies	CI
25-07-23	Brain Biotech Ag Appoints Ursula La Cognata as Member of Supervisory Board, Effective July 11, 2025	CI
25-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
25-05-20	Brain Biotech Takes Full Control of Dutch Unit Breatec, Plans New Continental Europe Hub	MT
25-05-20	BRAIN Biotech AG Announces Buy-Out of Minorities, New Continental European Production Site, and Expansion of Its Baking Application Center	CI
25-05-19	BRAIN Biotech AG acquired remaining minority stake in Breatec B.V.	CI
25-04-30	Brain Biotech Ag Updates Earnings Guidance for the Full Year 2025	CI
25-02-26	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
25-02-13	BRAIN Biotech AG Collaborates with PX Group on the PX Urban Mining Initiative	CI
25-01-14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
24-12-12	BRAIN Biotech AG - Analyst/Investor Day
24-10-03	BRAIN Biotech AG Announces Resignation of Wiltrud Treffenfeldt as Member of the Supervisory Board	CI
24-09-23	Brain Biotech Signs EUR129 Million Royalty Deal for Hereditary Angioedema Treatment Compound	MT
24-08-29	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
24-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
24-04-16	Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	MT
24-03-05	BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	CI
24-02-28	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

Employees

292

Sector

Environmental Services & Equipment

Calendar

Feb. 25 - Q1 2026 Earnings Release

More about the company